We are live on ! Find out more
CVET

Covetrus, Inc. Common Stock

Delisted

CVET was delisted on the 12th of October, 2022.

5 hedge funds and large institutions have $33.8K invested in Covetrus, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 241 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 2505 (-245)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 241

100% less funds holding in top 10

Funds holding in top 10: 70 (-7)

100% less capital invested

Capital invested by funds: $2.77B → $33.8K (-$2.77B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
-245
Holders Change %
-98%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
2
Closed
241
Calls
Puts
Net Calls
Net Calls Change

CVET Hedge Fund Activity: Q4 2022 in Review

5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Covetrus, Inc. Common Stock (CVET) for Q4 2022, worth a combined $33.8K — down 100% from $2.77B a quarter earlier.

Sellers outnumbered buyers: 241 funds closed out of CVET and 2 opened new positions — a net loss of 239 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Clayton Dubilier & Rice, exiting entirely with an estimated $704M sold.

  • 5 institutional investors held Covetrus, Inc. Common Stock (CVET) as of Q4 2022, down from 250 in Q3 2022.
  • Funds reported $33.8K of Covetrus, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 2 funds opened new Covetrus, Inc. Common Stock positions in Q4 2022 and 241 closed out, a net change of -239 holders.
  • The largest Covetrus, Inc. Common Stock seller in Q4 2022 was Clayton Dubilier & Rice, an estimated $704M sold.

Based on aggregated 13F filings for Q4 2022.